D. E. Shaw & Co., Inc. - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 102 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$47,824
-81.9%
27,173
-68.3%
0.00%
Q1 2023$263,737
-85.3%
85,629
-74.7%
0.00%
-100.0%
Q4 2022$1,797,341
+160.1%
339,121
+73.1%
0.00%
+100.0%
Q3 2022$691,000195,8840.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$2,692,0001.92%
SILVERARC CAPITAL MANAGEMENT, LLC 380,606$982,0000.30%
Pentwater Capital Management LP 4,967,227$12,815,0000.15%
Atom Investors LP 55,827$144,0000.06%
Corton Capital Inc. 14,978$39,0000.04%
Forefront Analytics, LLC 23,370$61,0000.03%
Delphia (USA) Inc. 15,799$41,0000.03%
Advisory Services Network, LLC 259,571$670,0000.02%
Laurion Capital Management LP 545,700$1,408,0000.02%
MCF Advisors LLC 59,659$154,0000.02%
View complete list of POSEIDA THERAPEUTICS INC shareholders